- Home
- ABSI vs GPAT Comparison
ABSI vs GPAT Comparison
Compare ABSI & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- GPAT
- Stock Information
- Founded
- ABSI 2011
- GPAT 2020
- Country
- ABSI United States
- GPAT United States
- Employees
- ABSI N/A
- GPAT N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- GPAT
- Sector
- ABSI Health Care
- GPAT
- Exchange
- ABSI Nasdaq
- GPAT NYSE
- Market Cap
- ABSI 318.2M
- GPAT 365.5M
- IPO Year
- ABSI 2021
- GPAT 2024
- Fundamental
- Price
- ABSI $4.35
- GPAT $10.21
- Analyst Decision
- ABSI Strong Buy
- GPAT
- Analyst Count
- ABSI 7
- GPAT 0
- Target Price
- ABSI $8.57
- GPAT N/A
- AVG Volume (30 Days)
- ABSI 7.6M
- GPAT 11.0K
- Earning Date
- ABSI 03-20-2025
- GPAT 01-01-0001
- Dividend Yield
- ABSI N/A
- GPAT N/A
- EPS Growth
- ABSI N/A
- GPAT N/A
- EPS
- ABSI N/A
- GPAT 0.30
- Revenue
- ABSI $4,207,000.00
- GPAT N/A
- Revenue This Year
- ABSI $8.57
- GPAT N/A
- Revenue Next Year
- ABSI $169.72
- GPAT N/A
- P/E Ratio
- ABSI N/A
- GPAT $33.86
- Revenue Growth
- ABSI N/A
- GPAT N/A
- 52 Week Low
- ABSI $2.45
- GPAT $9.98
- 52 Week High
- ABSI $6.72
- GPAT $10.25
- Technical
- Relative Strength Index (RSI)
- ABSI 66.14
- GPAT N/A
- Support Level
- ABSI $3.40
- GPAT N/A
- Resistance Level
- ABSI $4.01
- GPAT N/A
- Average True Range (ATR)
- ABSI 0.43
- GPAT 0.00
- MACD
- ABSI 0.07
- GPAT 0.00
- Stochastic Oscillator
- ABSI 97.13
- GPAT 0.00
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.